Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial-Reference-Cited by-同舟云学术

Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial

Published:2013-12 Issue:4 Volume:1 Page:306-316
ISSN:2213-8587
Container-title:The Lancet Diabetes & Endocrinology
language:en
Short-container-title:The Lancet Diabetes & Endocrinology

Author:

Gitelman Stephen E,Gottlieb Peter A,Rigby Mark R,Felner Eric I,Willi Steven M,Fisher Lynda K,Moran Antoinette,Gottschalk Michael,Moore Wayne V,Pinckney Ashley,Keyes-Elstein Lynette,Aggarwal Sudeepta,Phippard Deborah,Sayre Peter H,Ding Linna,Bluestone Jeffrey A,Ehlers Mario R

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference28 articles.

1. Projections of type 1 and type 2 diabetes burden in the U.S. population aged <20 years through 2050: dynamic modeling of incidence, mortality, and population growth;Imperatore;Diabetes Care,2012

2. Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study;Patterson;Lancet,2009

3. Genetics, pathogenesis and clinical interventions in type 1 diabetes;Bluestone;Nature,2010

4. Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial;Steffes;Diabetes Care,2003

5. Cyclosporin-induced remission of IDDM after early intervention. Association of 1 yr of cyclosporin treatment with enhanced insulin secretion;Diabetes,1988

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The opportunities and challenges of the disease-modifying immunotherapy for type 1 diabetes: A systematic review and meta-analysis;Pharmacological Research;2024-05

2. From islet transplantation to beta-cell regeneration: an update on beta-cell-based therapeutic approaches in type 1 diabetes;Expert Review of Endocrinology & Metabolism;2024-05

3. Abatacept increases T cell exhaustion in early RA individuals who carry HLA risk alleles;Frontiers in Immunology;2024-04-08

4. Pharmacological inhibition of tyrosine protein-kinase 2 reduces islet inflammation and delays type 1 diabetes onset in mice;2024-03-23

5. Type 1 diabetes: A new vision of the disease based on endotypes;Diabetes/Metabolism Research and Reviews;2024-02